← Leaderboards
Gilbert J. Cote
University Of Texas Md Anderson Can Ctr
$4,945,930
Attributed
$4,945,930
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $464.2K · FY2006–17$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,945,930 · 2
By mechanism
R01$2,698,364 · 1
P50$2,247,566 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Jasti S Rao$18,364,597
- Francis Ali-Osman$9,395,076
- Dawn S Chandler$5,230,006
- Funda Meric-Bernstam$12,297,463
- W K Alfred Yung$11,446,069
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellFibroblast Growth FactorReceptor ExpressionRna SplicingAstrocytesComparativePathway InteractionsCellsMolecular ProfilingCell LineMalignant NeoplasmsReceptorGrowthPropertyTumorLeadProtein IsoformsAstrocytomaOutcome ForecastMolecular OncologyNeoplasm /Cancer GeneticsGlioblastoma MultiformeGrowth Factor Receptors3t3 Cells
Grant awards (17)
Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers$464,200
P50 · FY2017 · CA · contact PI
Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers$452,744
P50 · FY2016 · CA · contact PI
Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers$454,648
P50 · FY2015 · CA · contact PI
Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers$438,770
P50 · FY2014 · CA · contact PI
Development and Validation of Novel Circulating Medullary Thyroid Cancer Markers$437,204
P50 · FY2013 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$249,791
R01 · FY2010 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$249,791
R01 · FY2009 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$249,791
R01 · FY2008 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$249,791
R01 · FY2007 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$257,250
R01 · FY2006 · CA · contact PI
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$262,500
R01 · FY2004 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$46,730
R01 · FY2004 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$262,500
R01 · FY2003 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$45,220
R01 · FY2003 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$262,500
R01 · FY2002 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$262,500
R01 · FY2001 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS$300,000
R01 · FY2000 · CA